Plain-English translation of NCT05266222 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are collecting samples (like nasal swabs or saliva) from people who have or may have respiratory infections like flu or COVID-19. These samples will be stored safely and used by scientists in the future to develop new vaccines, treatments, and laboratory tests. The goal is to create a resource that helps fight respiratory viruses for years to come.
Currently, researchers don't have enough stored samples of different respiratory viruses to develop and test new vaccines and treatments quickly. This trial builds a long-term library so scientists can work on better ways to prevent and treat these infections without waiting for future outbreaks.
You likely qualify if…
You likely don't qualify if…
If you join, you'll provide samples (such as nasal swabs, throat swabs, or saliva) that are collected at the NIH Clinical Center or another participating site. Some samples may be collected right away, and others may be requested if you've had a respiratory infection in the past. The study lasts up to 10 years, though your direct involvement may be much shorter — mainly the time it takes to collect your samples.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
United States
Enrollment target
~20,000 participants
Started
August 2022
Primary completion
December 2031
Age range
3 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rani S Athota, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.